(Q83199552)

English

Influence of PSA, PSA velocity and PSA doubling time on contrast-enhanced 18F-choline PET/CT detection rate in patients with rising PSA after radical prostatectomy

scientific article published on 10 January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22231016%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Influence of PSA, PSA velocity and PSA doubling time on contrast-enhanced 18F-choline PET/CT detection rate in patients with rising PSA after radical prostatectomy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22231016%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Orazio Schillaci

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22231016%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Enrico Finazzi Agro

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22231016%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Antonio Orlacchio

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22231016%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Roberta Danieli

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22231016%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Ferdinando Calabria

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22231016%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Mario Tavolozza

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22231016%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Cristiana Ragano Caracciolo

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22231016%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Roberto Miano

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22231016%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Giovanni Simonetti

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22231016%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

10 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22231016%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

number of pages

8

1 reference

based on heuristic

inferred from page(s)

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22231016%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

39

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22231016%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22231016%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

589-596

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22231016%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

https://scigraph.springernature.com/pub.10.1007/s00259-011-2030-7

0 references

Pre-treatment nomogram for disease-specific survival of patients with chemotherapy-naive androgen independent prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET-CT: a comparative study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nuclear medicine studies of the prostate, testes, and bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salvage radiotherapy for biochemical failure of radical prostatectomy: a single-institution experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of metastatic disease in men with biochemical failure following radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validation of increasing prostate specific antigen as a predictor of prostate cancer death after treatment of localized prostate cancer with surgery or radiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiation therapy for the management of biopsy proved local recurrence after radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

18F-choline PET/CT physiological distribution and pitfalls in image interpretation: experience in 80 patients with prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of patients with rising prostate-specific antigen after radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate specific antigen nadir achieved by men apparently cured of prostate cancer by radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate specific antigen only progression of prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluating the combined effect of comorbidity and prostate-specific antigen kinetics on the risk of death in men after prostate-specific antigen recurrence

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of whole-body 18F-choline PET/CT in disease detection in patients with biochemical relapse after radical treatment for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PSA et suivi après traitement du cancer de la prostate

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostatic-specific antigen doubling times in patients with prostate cancer: a potentially useful reflection of tumor doubling time

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imaging prostate cancer with 11C-choline PET/CT.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate-specific antigen kinetics in clinical decision-making during active surveillance for early prostate cancer--a review.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postoperative prostate-specific antigen velocity independently predicts for failure of salvage radiotherapy after prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Investigations with FDG-PET scanning in prostate cancer show limited value for clinical practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fusion imaging in nuclear medicine--applications of dual-modality systems in oncology.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2-[18F]fluoro-2-deoxyglucose positron emission tomography for the detection of disease in patients with prostate-specific antigen relapse after radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Positron emission tomography for prostate, bladder, and renal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-011-2030-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22231016%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22231016%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83199552&oldid=1807005846"